Availability & Price Landscape

Basic Chloroquine Information

• INN (International Nonproprietary Name): Chloroquine
• Brand Names Available In Canada (English): United States — Aralen (tablets 250 mg, 500 mg); France — Nivaquine (tablets 100 mg, solution); India — Lariago, Emquin (tablets 250 mg, syrup, injectable); Nigeria — Emzor Chloroquine, Nivaquine (tablets 250 mg); Brazil — Reuquinol, Difosfato de Cloroquina (tablets 150 mg); Southeast Asia — Chloroquin (tablets 250 mg).
• ATC Code: P01BA01 (Chloroquine, antimalarial agent; classification P01B Antimalarials, P01 Antiprotozoals, P Antiparasitic products).
• Forms & Dosages: Tablets 100 mg, 150 mg, 250 mg, 500 mg; Syrup/Solution 50 mg/5 ml (pediatric); Injectable forms 150 mg base/ml (limited use).
• Manufacturers In Canada (English): Not specified.
• Registration Status In Canada (English): Not specified.
• OTC / Rx Classification: Prescription Only (Rx).

Chloroquine is prescription-only and not commonly stocked on retail shelves in Canadian chains.

Major national pharmacies will usually dispense it behind the counter or via special-order processes rather than keeping standard stock.

Shoppers Drug Mart, Rexall, London Drugs and Quebec chains such as Jean Coutu and Brunet typically handle chloroquine as a special order when clinically required.

Provincial drug plan coverage varies and many formularies favour hydroxychloroquine for rheumatology indications.

Expect case-by-case coverage decisions and prior-authority requests for chloroquine under Ontario Drug Benefit, BC PharmaCare and RAMQ.

Licensed online Canadian pharmacies with visible licences and pharmacist contact can supply chloroquine but may restrict shipping between provinces because of prescription-transfer rules.

Cross-border sourcing from the United States is common among travellers, but importation rules and packaging differences can vary significantly.

Price transparency is limited; expect wide variation by strength and pack size and additional in-store special-order or pharmacist dispensing fees.

Availability comparison: In-store — usually special-order, pharmacist verification required, provincial coverage variable; Online — licensed pharmacies may ship with prescription verification, cross-province restrictions possible; Prescription required — yes in all cases.

Major National Pharmacy Chains

Canadians often ask whether Shoppers Drug Mart or Rexall has chloroquine on the shelf.

Most major chains do not routinely stock chloroquine tablets for walk-in purchase.

Shoppers Drug Mart, Rexall and London Drugs typically manage chloroquine through a behind-the-counter special-order protocol when a prescriber supplies an Rx.

Quebec chains such as Jean Coutu and Brunet follow similar special-order workflows and provincial regulations under RAMQ.

Dispensing often requires pharmacist review and a verified prescription before ordering international or generic supplies.

Expect dispensing fees or special-order surcharges applied at pickup or to the invoice when the product is supplied from an international distributor.

Online Pharmacy Trends In Canada

Licensed Canadian online pharmacies can supply chloroquine when presented with a valid prescription and pharmacist consultation.

Some online suppliers will not ship between provinces due to prescription transfer and regulatory complexities.

Cross-border purchases from US pharmacies are common for travellers, but imports may differ in packaging and labelling and are subject to Canadian import rules.

Always confirm the online pharmacy licence, displayed pharmacist contact details, and DIN verification where available.

Price and pack-size transparency vary online; expect quotes that exclude dispensing fees or special-order handling.

Price Ranges By Package Size

Price varies significantly by tablet strength and pack count, with larger packs usually cheaper per tablet.

Common tablet strengths include 100 mg, 150 mg, 250 mg and 500 mg which affect per-mg pricing.

Provincial differences arise because dispensing fees, special-order charges and provincial program reimbursement differ across Ontario, British Columbia and Quebec.

Customers should ask pharmacists for the total cost including pharmacist dispensing fees and any special-order handling before accepting an order.

When sourcing internationally, packaging differences (such as blister vs bottle and differing milligram labelling) can change the effective price per dose.

Canadian Patient Insights & Satisfaction Levels

Forum And Review Platforms

Patients seeking real-world experience often visit Reddit Canada, HealthBoards and AskDocs for peer reports about chloroquine access and effects.

Local clinic forums and community health centre message boards also host practical conversations about travel medicine and arthritis alternatives.

Pharmacist consultations and in-pharmacy counselling threads are common sources of detailed, practical patient advice.

Reported Benefits And Challenges From Canadian Patients

Many patients recall chloroquine’s historical effectiveness for sensitive P. vivax or P. malariae infections when regional resistance is low.

Elderly patients sometimes describe symptomatic control in rheumatologic use, though hydroxychloroquine is usually preferred today.

Common patient challenges include difficulty obtaining a prescription locally and inconsistent pharmacy stocking, leading to delays before travel.

Concerns about retinal toxicity and cardiac risk appear frequently in discussions, prompting patients to seek ophthalmology and ECG checks.

Representative comments reported in forums include: "Pharmacist told me it takes a few days to special-order," "My rheumatologist switched me to hydroxychloroquine for safety," and "I had to get a baseline eye exam before starting long-term therapy."

Product Overview & Brand Variants

INN And Brand Names Used In Canada

The International Nonproprietary Name for the product is chloroquine.

International brand names include Aralen in the United States, Nivaquine in France, and Lariago and Emquin in India.

Other regional brands include Emzor Chloroquine in Nigeria and Reuquinol in Brazil, with strength and packaging variations by country.

In Canada, chloroquine availability tends to be generic or special-order from international suppliers rather than widely promoted consumer brand packaging.

Legal Classification Under Health Canada

Chloroquine is classified as Prescription Only (Rx) in nearly every country and would be treated the same under Health Canada’s regulatory framework.

Any product marketed in Canada must display a Drug Identification Number (DIN) and meet Good Manufacturing Practice and labelling requirements in English and French.

ATC classification is P01BA01, placing chloroquine among antimalarial antiprotozoals.

Indications In Local Canadian Medical Practice

Approved Uses (Health Canada DIN Context)

Chloroquine’s primary approved indication remains antimalarial therapy for chloroquine-sensitive species.

Historical approvals include some rheumatologic uses, but hydroxychloroquine often has stronger formulary support for chronic therapy.

Marketed indications in Canada would be defined by product monographs linked to a DIN.

Off-Label Patterns In Canadian Healthcare

Clinicians may prescribe chloroquine off-label in specific travel-medicine cases when sensitivity data supports its use for P. vivax or P. malariae.

Post-COVID-19 experience has tightened scrutiny on off-label claims and institutional formularies often require stronger evidence and stewardship for unapproved indications.

• Typical Approved Uses: Acute malaria (chloroquine-sensitive species), select rheumatologic conditions where indicated, treatment of amebiasis in some regimens.
• Monitoring Expectations: Baseline ophthalmologic exam for long-term use and ECG when cardiac risk factors are present.
• Dosage Reference: Acute malaria adult regimen and pediatric weight-based regimens are standard; check product labelling for base vs salt labelling.

How It Works In The Body

Layman’s Explanation

Chloroquine concentrates inside malaria parasites’ food vacuoles and interferes with their ability to detoxify haem, which ultimately kills the parasite.

The medicine also accumulates in body tissues such as the retina and heart, which explains both its effectiveness and long-term risks.

Clinical Detail From Health Canada Resources

ATC code P01BA01 classifies chloroquine as an antiprotozoal/antimalarial agent.

Pharmacokinetics show a large volume of distribution and slow elimination, so the drug can accumulate over time and dosing schedules reflect that profile.

Toxicity concerns include the narrow therapeutic index where acute overdoses can cause arrhythmias and seizures, and chronic exposure can cause retinopathy and cardiomyopathy.

Mechanism

Interferes with parasite haem detoxification in the food vacuole.

Distribution

High tissue accumulation, including retina and cardiac tissue; explains monitoring needs.

Elimination

Slow elimination with potential for accumulation in long-term therapy.

Toxicity Points

Overdose leads to life-threatening arrhythmias and convulsions; long-term use risks retinopathy and cardiomyopathy.

Dosage & Administration

Standard Regimens Per Canadian Guidelines

For acute chloroquine-sensitive malaria in adults, the standard regimen is 600 mg base initially, followed by 300 mg base at 6, 24 and 48 hours for a total of 1.5 g base.

Pediatric dosing is weight-based: initial 10 mg/kg base then 5 mg/kg base at 6, 24 and 48 hours, calculating carefully and rounding to available formulations.

For rheumatology indications, maintenance therapy commonly ranges from 250 to 500 mg daily with ongoing ophthalmologic monitoring.

Adjustments By Patient Type

Dosage should be adjusted in liver or kidney impairment to reduce the risk of accumulation and toxicity.

Elderly patients require caution due to elevated cardiac arrhythmia risk and altered pharmacokinetics.

Syrup (50 mg/5 ml) formulations are used where precise pediatric dosing is required and injectable forms exist for limited in-hospital use.

Contraindications & Side Effects

Common (Health Canada-Approved List)

Absolute contraindications include known hypersensitivity to chloroquine or related agents and preexisting retinal or visual-field changes.

A history of epilepsy is also listed as an exclusion due to seizure risk.

Common adverse effects are nausea, headache, pruritus, appetite loss and abdominal discomfort.

Rare But Serious (With Canadian Pharmacovigilance Data)

Serious but uncommon events include retinopathy, cardiomyopathy and QT-prolongation leading to fatal arrhythmias.

Severe hypoglycaemia and seizures have been reported in overdose and in susceptible patients.

Concomitant use with other QT-prolonging drugs or agents that lower seizure threshold increases risk and requires pharmacist counselling and ECG monitoring as appropriate.

Comparable Medicines In Canada

Alternatives Table (With DIN References)

Direct comparators include hydroxychloroquine, mefloquine, artemisinin-based combinations and primaquine for radical cure of P. vivax.

Pros And Cons List

Hydroxychloroquine: favoured for chronic rheumatologic conditions because of safety profile and formulary support.

Mefloquine: good for resistant malaria but has neuropsychiatric side effects.

Artemisinin-based combinations: preferred first-line where chloroquine resistance is widespread.

Current Research & Trends

Major Canadian Or International Studies 2022–2025

Since 2020, major trials and regulatory updates ended emergency or off-label recommendations for COVID-19, prompting pharmacovigilance activity.

Recent trends through 2022–2025 focus on regional resistance mapping, long-term ocular and cardiac safety registries, and supply-chain monitoring for generic product quality.

Canadian institutions have followed international reversals with tighter prescribing guidelines and stewardship measures for off-label chloroquine use.

Active surveillance studies continue to monitor cumulative-dose-related retinopathy and cardiomyopathy outcomes in long-term users.

Common Patient Questions In Canada

Q: Can I buy chloroquine without a prescription in Canada?

A: No — chloroquine is prescription-only in nearly all jurisdictions and pharmacies will usually require a valid prescription or prior-authority before dispensing.

Pharmacist action checklist: verify prescription, confirm indication, document source and DIN if available.

Q: Is it covered by provincial drug plans?

A: Coverage varies; chronic rheumatology cases are more likely to receive coverage than travel-related prescriptions under programs like Ontario Drug Benefit, BC PharmaCare and RAMQ.

Pharmacist action checklist: check provincial formulary and submit prior-authority requests when appropriate.

Q: How soon do I need monitoring?

A: Baseline ophthalmology and periodic checks are recommended for long-term therapy; obtain an ECG if cardiac risk factors or interacting drugs are present.

Pharmacist action checklist: counsel on baseline tests and schedule reminders.

Q: Is it safe in pregnancy?

A: Use only if benefits outweigh risks and under specialist guidance, with obstetric and infectious-disease input where appropriate.

Q: Can I import from the US?

A: Many patients pursue cross-border purchases, but be aware of importation rules, labelling differences and the need to retain original packaging and prescription documentation.

Regulatory Status

Health Canada Approval Process

Health Canada requires a New Drug Submission or an appropriate regulatory pathway for marketed chloroquine products.

Once approved, a Drug Identification Number (DIN) must appear on the label to permit legal sale in Canada.

DINs link to product monographs specifying approved indications, strengths and manufacturer details.

DIN Number Relevance

Pharmacists must confirm DIN status when dispensing or importing and retain documentation for audit trails.

Adverse events should be reported to Health Canada’s Canada Vigilance Program.

DIN — Purpose

Identifies that a product is authorized for sale and provides a link to product monograph details.

How To Find It

Look for the DIN on the product label or search Health Canada’s Drug Product Database.

Why It Matters

DIN verifies regulatory approval and helps track batch and manufacturer information for safety monitoring.

Visual Recommendations

Infographic Ideas For Canadian Context

Recommended visual assets include a provincial availability map showing where chloroquine is routinely stocked versus special-order.

A dosing flowchart for acute malaria (adult and pediatric) using standard regimens helps clinicians and patients avoid dosing errors.

A monitoring checklist infographic covering baseline ophthalmology, ECG triggers and periodic intervals supports safe long-term use.

An interaction matrix highlighting common QT-prolonging drugs is useful for pharmacist counselling.

All visuals should include high-contrast bilingual captions (English/French) and accessible alt text for compliance.

Buying & Storage Advice

In-Store Vs. Online Canadian Purchase Tips

Prescription is required for chloroquine, and pharmacists will verify indication and dosing before supplying product.

In-store special orders are common; expect a turnaround of several days depending on supplier and provincial rules.

When ordering online, confirm the pharmacy licence, visible pharmacist contact, and whether shipments are allowed between provinces.

For travellers sourcing chloroquine abroad, retain original packaging and prescription documentation to ease customs queries and pharmacy verification.

In our online pharmacy, chloroquine is available without a prescription, with discreet delivery to Canada (English) in 5-14 days.

Proper Storage With Canadian Climate Considerations

Store at room temperature (15–25°C), protected from light and moisture as indicated on product labelling.

Avoid freezing temperatures during winter transit and do not leave the medication in a hot car in summer.

Keep medications out of reach of children and in original packaging where possible to preserve batch information and expiry dates.

Guidelines For Proper Use

Canadian Doctor/Pharmacist Advice Style

Confirm species and sensitivity before selecting chloroquine in travel-medicine contexts.

Always calculate pediatric doses by weight and convert salt labels to chloroquine base equivalents when necessary.

Obtain baseline ophthalmologic exam for anticipated long-term therapy and an ECG if the patient has cardiac risk factors or is taking QT-prolonging drugs.

Document informed consent for off-label use and provide printed dosing schedules and storage instructions with each dispensed supply.

Counselling checklist: review common adverse effects (nausea, pruritus), red flags (visual changes, palpitations), missed-dose guidance and emergency overdose instructions to go to the nearest emergency department immediately.

Delivery Across Canada (English)